Literature DB >> 17031008

Vitamin D status in a rural postmenopausal female population.

Joan M Lappe1, K Michael Davies, Dianne Travers-Gustafson, Robert P Heaney.   

Abstract

BACKGROUND: Inadequate vitamin D nutritional status is increasingly recognized as common in North American and European populations, but the extent of the shortfall and the parameters of the distribution for populations of interest remain uncertain.
PURPOSE: To report the distribution of values for serum 25-hydroxyvitamin D [25(OH)D] in a population of rural postmenopausal women, together with quantification of factors related to vitamin D status.
SETTING: Nine largely agrarian counties in eastern Nebraska (approximately 41 degrees N). PARTICIPANTS: A population-based sample of 1,179 women 55 years of age and older recruited into a four-year trial of calcium and vitamin D supplementation.
METHODS: Baseline biochemical, dietary, and anthropometric measurements obtained on entry into trial.
RESULTS: Serum 25(OH)D concentration at baseline varied cyclically with season, with the solar cycle explaining 2.9% of the total variance (P < 0.001). Mean seasonally adjusted 25(OH)D concentration was 71.1 nmol/L. Serum 25(OH)D also exhibited the expected inverse curvilinear relationship with serum parathyroid hormone (PTH), with the inflection point of the curve located at approximately 80 nmol/L. Supplements containing vitamin D were regularly taken by 59% of the cohort (median dose: 200 IU/d). Nevertheless, approximately 4% of all women had values below the laboratory reference range and more than two-thirds fell below 80 nmol/L. Seasonally adjusted serum 25(OH)D concentration was positively correlated with the size of daily vitamin D supplement dose, and negatively with age, weight, and body mass index (P < 0.01 for all). In stepwise multiple linear regression models, weight, age, and supplement dose were independently correlated with seasonally adjusted serum 25(OH)D, and together explained 19% of the total variance of adjusted 25(OH)D concentration. Women taking supplements had only one-sixth the chance of having a 25(OH)D value below the reference limit of the assay, compared to women who did not use supplements.
CONCLUSIONS: Approximately two-thirds of this rural population fell below 80 nmol/L, a value considered to be the lower end of the optimal range. Based on the slope of 25(OH)D on supplement dose observed in these women, it would require an additional vitamin D input of nearly 2000 IU/d to reach the goal of an RDA for vitamin D, i.e., to bring 97.5% of the cohort to levels of 80 nmol/L or higher.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031008     DOI: 10.1080/07315724.2006.10719551

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  37 in total

1.  Low urine pH and acid excretion do not predict bone fractures or the loss of bone mineral density: a prospective cohort study.

Authors:  Tanis R Fenton; Misha Eliasziw; Suzanne C Tough; Andrew W Lyon; Jacques P Brown; David A Hanley
Journal:  BMC Musculoskelet Disord       Date:  2010-05-10       Impact factor: 2.362

2.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 3.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

4.  Calcium supplementation: Results may not be generalisable.

Authors:  Joan M Lappe; Robert P Heaney
Journal:  BMJ       Date:  2008-02-23

5.  Effects of vitamin D insufficiency on bone mineral density in African American men.

Authors:  N Akhter; B Sinnott; K Mahmood; S Rao; S Kukreja; E Barengolts
Journal:  Osteoporos Int       Date:  2008-09-27       Impact factor: 4.507

Review 6.  DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation.

Authors:  Yu Zhou; Lan-Juan Zhao; Xiaojing Xu; An Ye; Dianne Travers-Gustafson; Boting Zhou; Hong-Wei Wang; Weidong Zhang; L Lee Hamm; Hong-Wen Deng; Robert R Recker; Joan M Lappe
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-12       Impact factor: 4.292

7.  Changes in vitamin D supplement use and baseline plasma 25-hydroxyvitamin D concentration predict 5-y change in concentration in postmenopausal women.

Authors:  Melissa A Kluczynski; Jean Wactawski-Wende; Mary E Platek; Carol A DeNysschen; Kathleen M Hovey; Amy E Millen
Journal:  J Nutr       Date:  2012-07-25       Impact factor: 4.798

8.  Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites.

Authors:  Jacqueline Chan; Karen Jaceldo-Siegl; Gary E Fraser
Journal:  Cancer Causes Control       Date:  2009-12-11       Impact factor: 2.506

9.  Clinical utility of vitamin d testing: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-02-01

Review 10.  Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health problem.

Authors:  Meinrad Peterlik; Steven Boonen; Heide S Cross; Christel Lamberg-Allardt
Journal:  Int J Environ Res Public Health       Date:  2009-10-02       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.